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Abstract
Background: Timely access is a challenge for providers of outpatient and community-based health services, as
seen by the often lengthy waiting lists to manage demand. The Specific Timely Appointments for Triage (STAT)
model, an alternative approach for managing access and triage, reduced waiting time by 34% in a stepped wedge
cluster randomised controlled trial involving 8 services and more than 3000 participants. Follow up periods ranged
from 3 to 10 months across the participating services in accordance with the stepped wedge design. This study
aimed to determine whether outcomes were sustained for a full 12 months after implementation of the STAT
model at each site.
Methods: Routinely collected service data were obtained for a total of 12 months following implementation of the
STAT model at each of the 8 services that participated in a stepped wedge cluster randomised controlled trial. The
primary outcome was time to first appointment. Secondary outcomes included non-attendance rates, time to
second appointment and service use over 12 weeks. Outcomes were compared to pre-intervention data from the
original trial, modelled using generalised linear mixed effects models accounting for clustering of sites.
Results: A 29% reduction in waiting time could be attributed to STAT over 12 months, compared to 34% in the
original trial. A reduction in variability in waiting time was sustained. There were no significant changes in time to
second appointment or in the number of missed appointments in the extended follow up period.
Conclusions: STAT is an effective strategy for reducing waiting time in community-based outpatient services.
At 12 months, small reductions in the overall effect are apparent, but reductions in variability are sustained,
suggesting that people who previously waited the longest benefit most from the STAT model.
Trial registration: This is a 12-month follow up of a stepped wedge cluster randomised controlled trial that
was registered with the Australia and New Zealand Clinical Trials Registry (ACTRN12615001016527).
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Background
As demand for health care services increases, providers
of health services often face challenges in ensuring
timely access [1, 2]. Adding incoming referrals to the
end of a waiting list is often used as a default strategy in
managing demand, sometimes supplemented with triage
systems of varying complexity [3, 4]. Excessive wait
times can lead to poorer outcomes for patients and
higher costs for health services as resources are diverted
from clinical care to administrative processes associated
with managing the waiting lists [5, 6]. When waiting lists
become unacceptably long, strategies such as a tempor-
ary increase in supply may be implemented, but do not
address underlying imbalances between supply and de-
mand. This leads to the recurrence of waiting lists once
the resources are withdrawn [7]. Fundamental changes
are needed to balance the distribution of resources with
the demand for the service for timely access to be
maintained.
The Specific Timely Appointments for Triage (STAT)
model of access and triage has demonstrated effective-
ness in reducing waiting times for community-based
outpatient services [8]. The primary principle of STAT
is that the rate of service demand is calculated, and the
corresponding number of new appointments required
each week to meet this demand is protected in clinician
schedules [9, 10]. All patients receive access to a prompt,
face to face assessment, but the assessing clinician then
makes prioritisation decisions about the ongoing allocation
of services based on the needs of the patient, in the context
of overall demand for the service. This is complemented by
a short-term, targeted intervention to reduce or clear the
backlog of waiting patients prior to the introduction
of protected appointments for new patients [9, 11].
In a stepped wedged randomised controlled trial, STAT
was progressively introduced across 8 community-based
outpatient services [9]. A 34% reduction in waiting time
was attributed to the intervention. A reduction in variabil-
ity in waiting time was also observed, with fewer patients
waiting long periods for a first appointment following the
intervention [8]. The reductions in waiting time and vari-
ability achieved in this trial were similar to pilot trials of
the STAT intervention conducted in community rehabili-
tation and outpatient physiotherapy settings [10, 12].
A criticism of many approaches to reduce waiting time
is that they result in short-term changes without sus-
tained benefits. Without demonstration of sustainability
of STAT and other approaches, it is difficult to know
whether early benefits are due to a short-term increase
in supply or due to a change in process. The period of
post intervention data collection in the stepped wedge
trial ranged from 3 to 10months after implementation
of STAT at each site (depending on the timing of inter-
vention at each site within the stepped wedge design)
[9]. The findings of the trial over this period were prom-
ising, but there remained an unanswered question about
the sustainability of the STAT model over a longer
period. This study aimed to determine whether the
STAT model was effective in sustaining a reduction in
waiting time for community-based outpatient services
over a 12-month period following its implementation.
Method
Design
Routinely collected service data were captured retro-
spectively from the 8 sites that participated in a stepped
wedge cluster randomised controlled trial investigating
the effect of STAT on waiting time [8]. The original trial
included pre and post data collection periods ranging
from 3 to 10months at each site, depending on the ran-
domised order of intervention at each site. The trial de-
sign therefore provided limited insights into the effects
of the intervention over time as longer term data (for
example 6–10months post intervention) were only avail-
able from a subgroup of the 8 sites that were rando-
mised earlier in the intervention sequence. For the
current study, data were collected over an additional
period at each site to complete a 12-month period fol-
lowing implementation of STAT at all sites (Fig. 1). The
collection of data for the original trial was completed
between October 2015 and April 2017. For this study,
additional data were collected through to November
2017 to enable a full 12-month follow up period at each
site. All patients who had their first appointment at each
site within the study period were included in the trial.
Data were not collected from new patients who attended
their first appointment during the 12 week implementa-
tion period at each site.
The original stepped wedge trial was registered with
the Australian and New Zealand Clinical Trial Registry
(ACTRN12615001016527) [9] and ethical approval was
provided by the Human Research Ethics Committee of
the health network both for the original trial and this
follow up study. Funding was provided by the Australian
National Health and Medical Research Council
(APP1076777) and the Victorian Department of Health
and Human Services. The original study was reported in
accordance with the CONSORT statement for reporting
of cluster randomised controlled trials. The majority of
items in the CONSORT statement are also reported in
the current study, but readers are also referred to the
protocol and findings of the original study for additional
detail [8, 9].
Setting
This trial was conducted at a metropolitan health net-
work providing care to a population of more than 700,
000 people in Melbourne, Australia. Eight sites providing
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community-based outpatient services within this network
participated in the trial. Community-based outpatient ser-
vices typically consist of allied health, medical and nursing
professionals working within multi-disciplinary teams,
providing care to people with chronic health conditions,
children with developmental disorders or supportive care
or rehabilitation services often associated with a hospital
admission. The 8 participating sites were purposefully
selected from 28 community-based outpatient services
within the network that participated in a previous qualita-
tive study exploring factors that contribute to waiting time
in these settings [3]. Services were selected on the basis
that they provided care over a series of appointments,
used waiting lists to manage demand and reported the
length of their waiting lists to be reasonably stable over
the previous 2 years [9].
Intervention
Prior to the implementation of STAT, all 8 sites used a
waiting list to manage demand for their service. A
detailed description of the intervention (STAT) has been
published in an online handbook [11]. The key elements
of the intervention include: (1) protection of the re-
quired number of new appointments to meet demand in
clinician schedules; (2) a targeted short-term interven-
tion to reduce the backlog of waiting patients; and (3)
redesigning workflow to ensure rapid access to a first
appointment, with clinicians then making prioritisation
decisions about the patient’s need for ongoing services
following their clinical assessment and within the
context of demand for their service. The short-term,
targeted interventions, used to reduce the backlog of
waiting patients prior to the introduction of protected
appointments, were individualised for each service and
were supported by a small budget [8].
Outcome measures
The primary outcome measure (waiting time) was the
number of days between the service receiving the refer-
ral and the patient’s first scheduled appointment. Sec-
ondary outcomes included number of days between the
first and second scheduled appointment, the total num-
ber of appointments over the 12 weeks following the first
scheduled appointment, and the number of times the
participant did not attend a scheduled appointment dur-
ing this 12-week period.
All primary and secondary outcome data were rou-
tinely collected by the participating services and entered
into a health network database. Manual checking of clin-
ician schedules and referrals were completed to verify
the accuracy of data obtained from the health network
databases.
Statistical analysis
Outcomes were modelled using generalised linear mixed
effects models with a negative binomial dependent vari-
able. A random intercept was included to account for
clustering of sites, and a random slope to allow for vari-
ation in the effect of intervention across sites, as sug-
gested by Davey et al. [13] Results were reported as
incidence rate ratios (IRR). A Gaussian linear mixed ef-
fects model was fitted to the log of waiting times as a
sensitivity analysis with no notable differences found
when comparing with the negative binomial model.
The cohort included in the 12-month follow-up incor-
porated people who attended the service anytime from
1 day to 12months after implementation. It was possible
that inclusion of data from those who attended early
after the implementation of STAT could mask changes
in the outcomes that appeared later in the follow-up
period. To address this issue, a sensitivity analysis was
conducted including the subgroup of patients who re-
ceived their first visit between 9 and 12months after im-
plementation. Although it was a smaller sample, this
cohort was independent of the participants included in
the original stepped wedge trial and was expected to
provide a more accurate reflection of the outcomes at
each service 12 months after implementation.
Service demand ratio (a ratio of the number of refer-
rals received over a 3-month period early in the trial and
a corresponding period in the following year) was
Fig. 1 Trial design during pre intervention period (original trial data), first 0–9 months post implementation and 9–12 months
post implementation
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calculated to provide an indication of stability of demand
at each site.
Previous trials have indicated that the greatest benefi-
ciaries of the STAT model are often the longest waiters,
as the model protects against low priority patients lan-
guishing on waiting lists for long periods of time, con-
stantly displaced, as higher priority patients are referred.
Therefore, in addition to the statistical analysis, observa-
tional data of the 90th percentile of waiting time for the
three cohorts (pre-intervention, full 12-month follow-up
and 9–12month subgroup) were used as an indicator of
ongoing effectiveness of the model for reducing delays
for the longest waiters.
Results
Data were collected from 4358 participants; 1252 in the
pre intervention period and 3106 in the post interven-
tion period. The pre and post periods had similar pro-
portions of male and female participants, but those in
the pre group were slightly younger on average (mean
40 v 43 years, p < 0.01) than the post group (Table 1).
The characteristics of the participating sites have been
described previously [8]. The demand ratio calculated
for the current study suggested more stable demand
over the data collection period than was observed in the
original trial, with consistent demand noted at 5 services
and increases in demand between 10 to 25% in 3
services.
Primary outcome
A 29% reduction in waiting time over the complete 12-
month follow up period across all sites was attributable
to the intervention (IRR 0.71, 95% CI 0.60 to 0.83,
Table 2). Waiting time reduced from a median of 42
days (IQR 19 to 86 days) pre-intervention to 31 days
(IQR 14 to 55 days) post-intervention. The reduction in
waiting time is less than the reduction of 34% observed
at the end of the stepped wedge trial. However, the 95%
confidence interval for the IRR in the current study is
0.6 to 0.83, suggesting that such magnitudes of reduction
are still possible.
The sensitivity analysis, including patients who re-
ceived their first appointment 9 to 12months after im-
plementation (n = 821), showed a 22% reduction in
waiting time (IRR 0.78, 95% CI 0.69 to 0.88) for patients
receiving an initial assessment during this period, com-
pared to those who received their first visit prior to the
intervention (Table 2). The 95% confidence interval for
the IRR is still significant indicating reductions in time,
although in comparison to the 34% reduction observed
within the main trial, these reductions are smaller.
Waiting time at the 90th percentile indicated that 90%
of patients, who were seen 9 to 12months after imple-
mentation of STAT, were seen within 81 days, compared
with 83 days over the full 12-month follow up period
and 139 days during the pre-intervention period.
The trial was not designed or powered to investigate
in-depth site level responses to the intervention. How-
ever, post-hoc site level observations at 12 months
(Fig. 2) illustrate variability between services, which, on
the one hand, may be consistent with the variability ex-
pected from sampling from the population of services.
On the other hand, although speculative, observations of
the services demonstrating increased waiting time during
follow up may be partly, but not fully, explained by fluc-
tuations in supply and demand. Three services experi-
enced an increase in demand in the subsequent 12
months (site 4, 5 and 7), but only one of these (site 5)
showed a substantial increase in waiting times during
the follow up period. However, of the other sites with
less success in maintaining reductions in wait time, site
6 had previously reported an unusual spike in demand
during the implementation period that may have had an
ongoing impact on patient flow through the service, and
site 1 experienced a disruption in supply during the 12-
month follow up period due to a key senior staff mem-
ber taking maternity leave. Overall, three of the sites
either maintained or further decreased reductions in
waiting time at 12 months, and four showed an initial
drop in waiting time followed by some deterioration of
effect, but did not return to pre-intervention waiting
times during the follow up period.
Table 1 Patient characteristics
Pre interventiona 12-month follow up Sensitivity analysis Significanceb
0 to 12month post
intervention
9 to 12month post
intervention
Pre to 0–12month Pre to 9–12month
n 1252 3106 821
Sex [n(%)]
Female 743 (59%) 1896 (61%) 498 (61%) p = 0.30 p = 0.58
Male 509 (41%) 1210 (39%) 323 (39%)
Age [years, mean (SD)] 43 (30) 40 (30) 39 (30) p < 0.01 p < 0.01
aData from original trial. Includes pre intervention periods for the participating sites ranging from 3 to 10 months, consistent with the stepped wedge trial
design [8].
bStatistical significance calculated using chi square for sex and t-tests for age
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Secondary outcomes
There were no significant differences in the time from first
to second appointment (Table 3). A small (6%) decrease
in the total number of appointments within the first 12
weeks after initial assessment from an average of 2.4 to 2.1
appointments was statistically significant over 12-month
follow up (IRR 0.94, 95% CI 0.89 to 0.98). Data from the
original trial suggested that STAT might have led to a
small increase in the number of patients missing appoint-
ments. This was not the case over the longer follow up
period, where there was an observed, but non-significant,
decrease in the number of missed appointments.
Considering only the cohort who attended the service
9 to 12months after the implementation of STAT,
Table 2 The effect of STAT on time from referral to first appointment (primary outcome)
Original trial 12-month follow up Sensitivity analysis
Pre-intervention Post-intervention 0 to 12month post intervention 9 to 12month post intervention
n 1252 1861 3016 821
Median (IQR) 42 (19 to86) 24 (13 to48) 31 (14 to55) 36 (13 to62)
Mean (SD) 60.0 (55.2) 35.6 (33.6) 40.0 (35.3) 41.9 (34.7)
Adj ratio IRR (95% CI) Reference 0.66 (0.52 to 0.85) 0.71 (0.60 to 0.83) 0.78 (0.69 to 0.88)
IRR incident rate ratio, Adj ratio Adjusted ratio indicates that other factors, such as potential confounders, have been included in the model. IRR calculated using a
generalised linear mixed effects model
Fig. 2 Mean waiting time by study site
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observed values of these secondary outcomes were simi-
lar to those collected over the full 12-month follow up
period. Time from first to second appointment remained
unchanged. The small reduction in the number of ap-
pointment provided over the first 12 weeks was main-
tained, although this finding was not significant given
the reduced sample size in this subgroup. In contrast,
data on missed appointments for this subgroup showed
a statistically significant 22% decrease from 0.4 to 0.3
missed appointments per patient over this time period
(IRR: 0.78, 0.63 to 0.97, Table 3).
Discussion
Reductions in waiting time achieved through introduc-
tion of the STAT model remained statistically significant
at 12-month follow up, although there may have been
some small reductions in the gains measured in the ori-
ginal trial. However, patients seen for the first time in
the period 9 to12 months following the intervention, still
experienced a 22% reduction in waiting time compared
to those seen for the first time prior to the intervention
controlling for differences between sites.
The findings that significant effects were still seen 9–
12months after intervention is encouraging, but there
remains some uncertainty about whether this is a long
enough time period to measure sustainability. It needs
to be considered whether the effects observed at this
time were the direct result of a temporary injection of
resources to reduce the backlog, which can be expected
to continue to wash out with time. Previous research has
shown that short term injections of funding to reduce
backlogs are ineffective, with waiting lists beginning to
grow back as soon as the resources are withdrawn [14].
Much of this evidence is drawn from efforts to reduce
surgical waiting list with temporary increases in activity;
there is little to shed light on how long effects of
different levels of temporary investment can be expected
to last in community outpatient settings. However, the
temporary resources provided in this study were modest,
and had been expended prior to the beginning of the
post implementation period; that is there were no on-
going resources supplied such as continued additional
staff or additional clinics. Furthermore, all sites had ac-
cess to similar levels of resources to assist with backlog
reduction, but there was observed to be variation in
response over time. This suggests that outcomes at 12
months were not a simple function of the additional in-
vestment, but were influenced by service level factors
and the other components of the STAT model.
Perhaps the most clinically significant difference be-
tween the pre-intervention data and follow up data is
the reduction in waiting time for the longest waiters in
the sample. Observations of waiting time at the 90th
percentile suggest that STAT continued to be very ef-
fective in reducing the tail of “long waiters” 12months
after implementation, with no indication of this effect
diminishing. Patients given classifications as low priority
and waiting excessively long periods for treatment, or
not being seen at all, is a well document problem associ-
ated with the use of waiting list and priority systems
[15]. STAT provides a sustainable way to ensure that
these patients are seen in a timely manner without ad-
versely affecting other aspects of patient care.
One explanation for the diminishing effect of the
model over time may be that services regularly face fluc-
tuations in demand and supply [1]. Although STAT is
designed around the concept of balancing demand with
supply, it cannot control for a long and unexpected
reduction in supply or sudden, excessive increase in de-
mand. Observations of site level data provide prelimin-
ary support for this hypothesis. For example, during a
long period of absence due to illness of a staff member,
Table 3 The effect of STAT on secondary outcomes
Original trial 12-month follow up Sensitivity analysis
Pre-intervention Post intervention 0 to 12month post intervention 9 to 12month post intervention
n 1252 1861 3016 821
Appointments missed per patient, n
Mean (SD) 0.4 (0.9) 0.5 (0.7) 0.3 (0.7) 0.3 (0.7)
Adj Ratio (95% CI) Reference IRR: 1.18 (1.04 to 1.35) IRR: 0.86 (0.69 to 1.07) IRR: 0.78 (0.63 to 0.97)
Time from 1st to 2nd appointment, days, n
Mean (SD) 28.8 (20.0) 28.5 (18.5) 29.8 (20.5) 28.3 (19.0)
Adj Ratio (95% CI) Reference IRR: 1.03 (0.98 to 1.09) IRR: 1.06 (0.94 to 1.19) IRR: 1.04 (0.96 to 1.14)
Appointments in first 12 weeks, n
Mean (SD) 2.4 (2.1) 2.1 (1.6) 2.1 (1.6) 2.0 (1.6)
Adj Ratio (95% CI) Reference IRR 0.99 (0.93 to 1.05) IRR: 0.94 (0.89 to 0.98) IRR: 0.89 (0.73 to 1.10)
Adj ratio Adjusted ratio indicates that other factors, such as potential confounders, have been included in the model
IRR calculated using generalised linear mixed effects models
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there may be no way for a service to continue to provide
the required number of new appointments to keep up
with demand, gradually increasing the time to the next
available assessment appointment. There are strategies
that can be used to mitigate this effect, such as main-
taining a contingency in budgets to cover unexpected
leave or planning ahead for known disruptions. How-
ever, it is likely to be necessary to accept that there may
need to be a periodic “reset”, in which there is a short-
term focus on reducing excess waiting time that may be
re-emerging, checking supply and demand calculations
and making any necessary alterations to scheduling to
ensure the supply of new assessment appointments in
sufficient to balance demand. Although the need to
monitor the balance between demand and new appoint-
ments was discussed during implementation, the level of
adherence to this aspect of STAT after project support
was withdrawn is not known. Having trigger points for
discussion when times to the next available appointment
reach certain thresholds and ensuring that contingency
plans are in place are likely to play an important role in
sustaining gains made by implementing STAT.
Diminishing effects over time may also be explained
by the circumstances in which the intervention was im-
plemented at the participating sites. The timing of the
implementation of the intervention was dictated by the
stepped wedge cluster randomised controlled trial design
[16]. This meant that support from project officers was
available only over a specified period. The motivation for
introducing the intervention was also driven by the pro-
ject team, rather than by a champion within the services
[17]. Furthermore, in agreeing to be part of the project
the service providers committed to continuing with the
STAT model for the duration of the project, but made
no commitment beyond the end of the stepped wedge
trial period. It is therefore possible that the intervention
had not been supported for long enough to be truly em-
bedded into practice by the time support of the project
team had been withdrawn.
A ‘real world’ setting, outside of a research study, is
likely to present different issues in relation to sustain-
ability of STAT as an intervention to reduce waiting
time. First, without an artificial timeline in which to con-
duct the process of backlog reduction, service providers
have a much better opportunity to reduce the existing
waiting list as much as possible before implementing
STAT. Maintaining momentum for change over a longer
period is more likely where the need for change is recog-
nised as a priority from an organisational, executive and
managerial perspective [17]. Internal champions and a
highly motivated team with a shared goal to reduce wait-
ing times are therefore likely to improve sustainability of
the model. STAT is a complex intervention, requiring
skills in understanding and analysing data, attention to
principles of change management, and a new way of
thinking about prioritisation [11, 18]. Leadership, drive
and an appropriate skill set are therefore required for
successful implementation and sustainability of the
STAT model. The current evaluation suggests that bene-
fits can be maintained over 12 months, but questions
remain about whether sustainability could be further im-
proved with additional support over a longer time-
period.
Examination of data over a longer period resolved the
increase in failure to attend rate in the post intervention
period observed in the original study. This unexpected
finding in the stepped wedge cluster RCT was in con-
trast to previous literature that suggests that reduced
waiting times are likely to be associated with a reduction
in the rate of people who do not attend appointments
[19, 20]. However, over a 12-month follow-up this effect
was no longer observed; conversely, the number of
missed appointments was observed to reduce by 14%
when measured over 12 months, although the effect was
not statistically significant. One explanation for the fail-
ure to attend results in the original study is that short-
term increases in failure to attend rates occurred due to
service disruptions associated with the process of dealing
with the backlog and changing the model of care. For
example, less attention may have been given to the ap-
pointment reminder systems that were in place at the
participating services during this period. Once the new
processes had been established, attention could return to
standard work associated with smooth running of the
clinic, and shorter wait times began to contribute to
overall reductions in non-attendance.
This was a pragmatic evaluation of data routinely col-
lected over a 12-month period following implementation
of an intervention within a stepped wedge cluster rando-
mised controlled trial. Data were collected retrospect-
ively and limited to variables that were routinely
collected by the participating sites. Some verification of
data was possible through cross-referencing multiple
data sources (such as clinician diaries with referral data)
but limitations of retrospective data, such as the possibil-
ity of inaccurate or incomplete records, must be consid-
ered in interpretation of findings. Site level observations
presented must also be treated with caution. The study
was not powered for site by site analysis, and the data
presented are post-hoc. However, these are included to
illustrate the level of variability between services. Further
exploration of the causes of variation and predictors of
success in implementing STAT are areas for further
research.
We also acknowledge that the STAT model contains
multiple components, including a short-term, targeted
intervention to reduce the existing backlog and ongoing
protection of time for new assessments to match typical
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service demand. It could be argued that the design of
this study is lacking in capacity to provide any insights
into the relative contributions of the different elements
of the intervention, and could be enhanced by inclusion
of statistical analysis of interaction effects with a moder-
ator analysis. However, STAT intentionally brings to-
gether a combination of evidence-based interventions to
reduce waiting time which are not intended to work
alone. Short-term increased in activity can reduce back-
logs but do not lead to lasting change; preserving time
for new appointments at the rate of demand without ad-
dressing the backlog will stabilise waiting time but will
not reduce it. STAT should therefore be seen as a pack-
age, rather than a series of concurrent interventions that
can be evaluated in isolation.
Conclusion
The STAT model reduced waiting time in community-
based outpatient services. This 12-month follow up
shows that a significant benefit in overall waiting time
continues to be observed after 12 months, although
some small reductions in the effect over time are appar-
ent. One key benefit, the reduction in variability and
more timely service to people who previously waited the
longest, appears to be sustained over 12 months. STAT
is an effective strategy for reducing waiting time in these
services, but is likely to require ongoing monitoring
from champions within the service, including associated
contingency planning and a willingness to, periodically,
‘reset’ the system after unexpected disruptions, to be
fully sustainable over the long term.
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